Data Integrity has become the “buzz” word in the pharmaceutical industry and; perhaps; rightfully so. Each regulatory application or approved product carries with it a commitment from the company to the regulatory authority that the company will produce only the finest quality products for patient use. The recent spate of observations from all major regulatory authorities to companies around the globe indicates that many may not taking their commitment seriously. This conference brings together eleven (11) of the most knowledgeable experts in the industry to present relevant information; concerns; and solutions related to managing and maintaining data integrity in the pharmaceutical industry. Former EMA Head of GMP Compliance; David Cockburn; Ph.D.; and current MHRA Data Integrity expert Stephen Grayson will; for example; discuss the current focus on Data Integrity within the regulatory authorities. Industry; on the other hand; will discuss its efforts to manage the ever-increasing volume of information within the company using the current tools at its disposal; while keeping in mind the real costs incurred due to over-zealous pursuit of data integrity perfection. Practical solutions to real problems will be discussed to allow each of the attendees to hear solutions to their real-world problems and take them home.